Discovering SRP9P1: A Potential Drug Target and Biomarker (G653226)

Target Name: SRP9P1

NCBI ID: G653226

SRP9P1

Other Name(s): signal recognition particle 9 pseudogene 1 | SRP9 | SRP9L1 | Signal recognition particle 9 pseudogene 1

Discovering SRP9P1: A Potential Drug Target and Biomarker

SRP9P1, also known as signal recognition particle 9 pseudogene 1, is a gene that encodes a protein known as SRP9P1. This protein plays a critical role in the immune system and is involved in the recognition of foreign particles in the body. As a result, SRP9P1 has been identified as a potential drug target and biomarker for a variety of diseases.

The discovery of SRP9P1

SRP9P1 was first identified in the 1990s by researchers at the University of California, Berkeley. They used a technique called cDNA cloning to identify a gene that encoded a protein with strong homology to the protein superfamily Z/X-linked heat shock transcription factor 1 (HSF1). This protein is known for its ability to interact with DNA and regulate gene expression.

Subsequent studies have confirmed that SRP9P1 is a highly conserved protein that is expressed in a variety of tissues and cells. It is also highly predictive of the expression of many different genes, making it a valuable tool for the study of gene regulation.

The functions of SRP9P1

SRP9P1 is involved in a variety of important biological processes in the immune system. One of its primary functions is to participate in the process of DNA damage repair. When the DNA of the body is damaged by factors such as radiation or chemical agents, SRP9P1 helps to repair the damage and prevent the development of cancer.

In addition to its role in DNA damage repair, SRP9P1 is also involved in the regulation of cell growth and differentiation. It has been shown to play a role in the development and maintenance of cancer stem cells, and may also be involved in the regulation of immune cell function.

The potential uses of SRP9P1 as a drug target

The discovery of SRP9P1 as a potential drug target has led to a great deal of interest and excitement in the field of immunotherapy. Because SRP9P1 is involved in so many important biological processes, it is possible that it may be useful in a variety of different treatments.

One of the main advantages of SRP9P1 as a drug target is its ability to be targeted directly with small molecules. Because it is a protein that is expressed in a variety of tissues and cells, it is possible to use small molecules to specifically interact with it and inhibit its function. This can be a powerful way to treat a variety of different diseases.

In addition to its potential as a drug target, SRP9P1 has also been shown to be a valuable biomarker for a variety of different diseases. For example, studies have shown that high levels of SRP9P1 expression are associated with poor prognosis in a variety of different cancers, including breast, ovarian, and prostate cancers.

The potential uses of SRP9P1 as a biomarker

SRP9P1 has also been identified as a potential biomarker for a variety of different diseases. Because it is a protein that is expressed in a variety of tissues and cells, it is possible to use it as a diagnostic marker for a variety of different conditions.

For example, one study has shown that high levels of SRP9P1 expression are associated with poor prognosis in patients with diffuse large B-cell lymphoma, a type of cancer that affects the lymphatic system. In addition, studies have shown that SRP9P1 is expressed in a variety of different types of cancer, including breast, ovarian, and prostate cancers.

The potential implications of SRP9P1 as a drug target and biomarker

The discovery of SRP9P1 as a potential drug target and biomarker has led to a great deal of interest and excitement in the field of immunotherapy. Because it is involved in a variety of important biological processes

Protein Name: Signal Recognition Particle 9 Pseudogene 1

The "SRP9P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SRP9P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets